Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal estradiol for bone mineral density in adolescent girls with anorexia nervosa
2017-004729-34Phase 2Active
- Sponsor
- University of Freiburg Medical Center Department of Child and Adolescent Psychiatry
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estradiol and dydrogesterone in anorexia nervosa (AN) (2 arms), sponsored by University of Freiburg Medical Center Department of Child and Adolescent Psychiatry. Primary endpoint: Change in lumbar spine bone mineral density z-score. Started Jan 2019; status: active.
02
Drugs
estradioldydrogesterone
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2017-004729-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004729-34.